Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp79 | Diabetes Complications | ECE2018

Outcomes of hyperglycemia in patients with and without diabetes mellitus hospitalized for infectious diseases

Gorshtein Alexander , Shimon Ilan , Akirov Amit

Context: Hyperglycemia is common among patients with and without diabetes mellitus (DM) hospitalized for infectious diseases. The long-term outcomes of hyperglycemia have not been adequately studied in this population.Objective: Examine the prognostic implications of hyperglycemia and the importance of glycemic control in patients with and without DM during hospitalization for infectious diseases.Methods: Historical prospectively c...

ea0081p384 | Endocrine-Related Cancer | ECE2022

Appendiceal neuroendocrine neoplasms diagnosed during pregnancy-case series and review of the literature

Twito Orit , Amit Akirov , Chava Rosenblum Rachel , Herzberg Dana , Oleinikov Kira , Pnina Rotman-Pikielny , Glasberg Simona

Introduction: Although appendicitis occurs in approximately 1:1000 pregnancies, appendiceal neuroendocrine neoplasm (ANEN) diagnosis during pregnancy is very rare. Data on presentation, treatment and prognosis is scarce.Aim: To describe ANEN cases diagnosed during pregnancy.Materials and Methods: A retrospective appraisal of 7 consecutive ANEN patients diagnosed during pregnancy from four Israeli tertiary medical centers and compar...

ea0081p653 | Pituitary and Neuroendocrinology | ECE2022

Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma

Rudman Yaron , Duskin-Bitan Hadar , Masri-Iraqi Hiba , Akirov Amit , Shimon Ilan

Objective: To study the baseline characteristics predicting hypogonadotropic hypogonadism (HH) persistence in men with macroprolactinoma following medical treatment with cabergoline.Design: Retrospective cohort study conducted in a tertiary pituitary center.Methods: Male patients diagnosed with macroprolactinoma and HH that received cabergoline treatment with subsequent prolactin normalization were included: men that achieved eugon...

ea0063gp119 | Diabetes: Late Complications | ECE2019

Glycemic variability and mortality in patients hospitalized to general surgery wards

Gorshtein Alexander , Shochat Tzipora , Dotan Idit , Diker-Cohen Talia , Shimon Ilan , Akirov Amit

Background: Glucose variability (GV) is common among hospitalized patients but the prognostic implications among patients hospitalized to surgical wards are unknown.Objective: Investigate the association between GV, length of stay (LOS) and mortality.Methods: Historical prospectively collected data of patients ≥18 years, hospitalized to general surgery wards between January 2011–December 2017. GV was assessed by coeffici...

ea0081rc7.3 | Rapid Communications 7: Pituitary and Neuroendocrinology 2 | ECE2022

Pituitary microadenoma vs macroadenomas in cushing’s disease: does size matter?

Akirov Amit , Shimon Ilan , Yosi Manisterski , Aviran-Barak Nirit , Nadler Varda , Alboim Sandra , Kopel Vered , Tsvetov Gloria , Hirsch Dania

Background: The majority of adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas are less than 10 mm in diameter and are described as microadenomas, while corticotroph macroadenomas (≥10 mm) are a less common cause of Cushing’s disease. Prior reports on the differences of clinical and biochemical behavior of corticotroph microadenomas and macroadenomas were inconsistent.Objective: Describe the clinical and biochemical characteristic...

ea0081p255 | Late-Breaking | ECE2022

Cushing syndrome in older women: age-related differences in disease origin and clinical manifestations

Akirov Amit , Shimon Ilan , Yosi Manisterski , Aviran-Barak Nirit , Nadler Varda , Alboim Sandra , Tsvetov Gloria , Hirsch Dania

Background: Adrenocorticotropic hormone (ACTH)-producing pituitary adenoma is the most common cause of endogenous Cushing syndrome (CS), but the relative proportion of adrenal causes of CS is rising. Limited data are available on the clinical manifestations and cause of CS in older women.Objective: Determine the clinical presentation, biochemical profile, and cause of CS in women 65 years of age and older, compared with younger patients with CS.<p cl...